Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
- WCBP (389)
- Cell & Gene Therapy Products (189)
- CE Pharm (187)
- Mass Spectrometry (173)
- CMC Strategy Forum Europe (157)
- Higher Order Structure (109)
- AT Europe (109)
- Bioassays (107)
- CMC Strategy Forum Japan (105)
- CMC Strategy Forum (78)
- CMC Strategy Forum North America Winter (67)
- CMC Strategy Forum North America Summer (61)
- CMC Strategy Forum Latin America (40)
- CGTP Summit (29)
- CMC Strategy Forum China (29)
- CMC Strategy Forum North America Fall (14)
- CGTP Europe (11)
- Symposium on mRNA (11)
- Consultants' Network (10)
- Biophysics Working Group (8)
- CGTP Virtual Summit (7)
- NorCal Regional Forum (6)
- Netherlands Area Biotech Discussion Group (5)
- Virtual Europe Discussion Group (5)
- DC Area Scientific Discussion Group (4)
- Biotech Working Group (2)
- Midwest Regional Forum (2)
- CMC-Vaccines Working Group (1)
Filter By Tags
-
It’s All About Consistency: Change of Reference Standards for Potency Assessment in Clinical Phases
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/cmc-europe/cmce2022_120x120_landing081fc709-e251-4f5c-b51b-cd75002e3310.jpg?sfvrsn=49a2fcbf_3)
Speaker Presentation: CMC Strategy Forum Europe 2025Beck Hermann, F. Hoffmann-La Roche Ltd., 2025 -
Subcutaneous Biologics: Advancing High-Concentration Technologies and Justifying CQA Specification Limits Through Translational Immunogenicity Models – Status Update
Speaker Presentation: CMC Strategy Forum Europe 2025Bechtold-Peters Karoline, Novartis Pharma AG, …
-
ADCs and AxCs: Summary of a Recent EFPIA Member Survey on Antibody Conjugates
Speaker Presentation: CMC Strategy Forum Europe 2025Bechtold-Peters Karoline, Novartis Pharma AG, …
-
Revolutionizing Regulatory Submissions Through Digital Innovation
Speaker Presentation: CMC Strategy Forum Europe 2025Abernathy Michael, Amgen Inc., 2025
-
CMC Strategy Forum Europe 2025 Scientific Program
Scientific Program: CMC Strategy Forum Europe 2025
-
CMC Strategy Forum Europe 2025 Summary Infographic
Summary Infographic: CMC Strategy Forum Europe 2025
-
Streamlining Agile MS Workflows
with Genedata
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/mass-spec/2024/ms2024_120x120_landing.jpg?sfvrsn=8cbbea64_9)
Speaker Presentation: Mass Spec 2025Cazy Aaron, Eli Lilly and Company, 2025 -
New Paradigm for Charge Variant Characterization Utilizing 'Discovery' Assisted Fractionation Strategy
Speaker Presentation: Mass Spec 2025Xiao Yongsheng, WuXi Biologics, 2025
-
Mechanistic Insights into non-mAb Aggregation Using MS-Cleavable Linker
Speaker Presentation: Mass Spec 2025Whitty-Léveillé Laurence, Merck & Co., Inc., …
-
Applications of Mass Spectrometry in Biopharmaceutical Discovery: From Small Molecules to Proteins
Speaker Presentation: Mass Spec 2025Sahasrabuddhe Aniruddha, Amgen Inc., 2025
-
Automation and HTP Mass Spectrometry to Accelerate Biotherapeutics Discovery
Speaker Presentation: Mass Spec 2025Pomerantz Steven C, Johnson & Johnson, 2025
-
Diving Into the Complexities of Non-Natural Amino Acid Antibodies with Innovating Mass Spectrometry Approaches
Speaker Presentation: Mass Spec 2025Nanda Hirsh, Johnson & Johnson, 2025
-
A Robust and Versatile New Peak Detection Workflow to Facilitate the Implementation of the LC-MS Multi-Attribute Method (MAM) from Research to Commercialization
Speaker Presentation: Mass Spec 2025Merkle Patrick, Novartis Pharma AG, 2025
-
Monitoring Intact AAV and AAV Building Blocks Through Individual Ion Mass Spectrometry
Speaker Presentation: Mass Spec 2025McGee Jack, ImmPro, Inc., 2025
-
Evaluating Antigen-Antibody Interactions: A Comparative Study of Higher-Order Structural MS Methods
Speaker Presentation: Mass Spec 2025Ma Yiran Silvia, Eli Lilly and Company, 2025
-
Leveraging Mass Spectrometry Analytical Methods in FDA Cell & Gene Therapy Regulatory Submissions: Current Uses and Future Opportunities
Speaker Presentation: Mass Spec 2025Lucas Tiffany, ELIQUENT Life Sciences, 2025
-
Integrating Mass Spectrometry-Based Structural
Proteomics and Molecular Docking to Analyze Ebola
Protein-Host Binding Interfaces
Speaker Presentation: Mass Spec 2025Kuang Xinyi Cynthia, Washington University in St. Louis, 2025
-
LCMS Assays for mRNA CQAs: A Development Story
Speaker Presentation: Mass Spec 2025Johnson Alex, Aldevron, LLC, 2025
-
Unraveling the Metabolic Regulatory Mechanisms Driving Product Expression and Quality in CHO Cell Cultures Using a Multi-Omics Approach
Speaker Presentation: Mass Spec 2025Gorre Elsa, Johnson & Johnson, 2025
-
Employing Electron Activated Dissociation (EAD) fragmentation to identify reactive N-oxide impurities in Lipid Nanoparticles (LNPs)
Speaker Presentation: Mass Spec 2025Crowe Adam, Cytiva, 2025